Dr. Ashley Feinsinger is bioethics faculty in the Department of Medicine at the David Geffen School of Medicine at UCLA. Her research pursues questions at the intersection of ethics, philosophy of language, and neuroscience, with a focus on invasive basic brain research in ... humans. She received her PhD in Philosophy from UCLA, completed the Medical Education Fellowship from DGSOM at UCLA, and Advanced Training in Health Care Ethics Certification from the University of Washington. She has published on a range of topics, including medicalization and the ethics of non-therapeutic research with implanted devices. Funded by the NIH BRAIN Initiative, she leads a neuroethics lab focused on understanding patient-participant motivations for enrolling in invasive brain research. Through comparing patient values with those of researchers and the public, she aims to incorporate the patient perspective in research design. Her approach to neuroethics is interdisciplinary, collaborating with neurosurgeons, behavioral psychologists, and patient-participants to address conceptual questions about exploitation and trust, as well as practical questions about patient engagement and consent.

President & CEO of StressMarq Biosciences Inc., a research reagent company with primary product lines in neurodegenerative diseases and cellular stress based in Victoria (BC), Canada. Successful Senior Scientific Business Executive with demonstrated expertise growing markets ... revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified success in moving technical businesses into new international arenas. Author of numerous peer-reviewed articles, and holder of several patents.

I am an affective and systems neuroscientist leading the Translational Neuromodulation Lab in the Department of Neurosurgery at Baylor College of Medicine. My lab seeks to leverage targeted neural stimulation, electrophysiology, neuroimaging, and cognitive neuroscience tasks to ... understand the neural bases of affective and social cognitive dysfunction. This program of research has led to the identification of a novel stimulation-based strategy for evoking positive affect and anxiolysis, for which our team has a United States Patent awarded. I was honored when this project was selected as the featured cover article at the Journal of Clinical Investigation, with coverage by the NIH Director's Blog4. This nascent program of research has garnered academic and public media attention, and I am fortunate to serve as PI on a variety of NIH-funded projects in the intracranial research domain (KL2TR000455, K01MH116364, R21NS104953, R01MH127006).

Karen David currently oversees the Circuits and Integrated Approaches portfolio of the BRAIN initiative. She joined the Systems and Cognitive Neuroscience cluster in 2013. Over the years, she has served the BRAIN Initiative in various capacities, including as Project Officer ... Scientific Review Officer, and Program Analyst to her current role as Program Director. Karen has also worked on various special projects including coordinating the review activities of the Biospecimen Repository Acquisition Committee (BRAC) for the Parkinson's Disease Biomarkers Program. Before joining extramural research, Karen did her postdoctoral fellowship in Molecular Biology and Genetics at Johns Hopkins School of Medicine. She earned a B.S. from the University of the Philippines and a Ph.D. in Cellular and Molecular Medicine from the Johns Hopkins University School of Medicine.

Mauricio Rangel-Gomez is an engineer and neuroscientist with expertise across domains and organisms in systems neuroscience, using a diversity of techniques and approaches, including electrophysiology, brain imaging, and neuropsychopharmacology. Mauricio earned bachelor's degrees ... in psychology (Universidad El Bosque) and engineering (Universidad de los Andes) in Colombia, and a master's degree in neuropsychology (Maastricht University) and doctorate in cognitive neuroscience (Vrije Universiteit Amsterdam) in the Netherlands. Before coming to NIH, Mauricio conducted basic and applied research in humans and non-human primates aiming to understand the mechanisms of memory, attention, and reward responses at UC Berkeley and U Maryland. Mauricio joined the government through a fellowship to work at FDA, where he managed the FDA-NIH cooperation for the funding of projects aimed to support regulatory science. Currently, Mauricio is a program officer at NIMH where he manages the Neural Substrates of Learning and Memory program; Mauricio is also actively engaged in DEIA activities within NIMH and NIH-wide.

Dr. Natalie Trzcinski oversees the cooperative agreement BRAIN Technology Integration and Dissemination (U24) program within the NINDS Division of Neuroscience and the BRAIN Initiative. She joined NINDS in 2017 and during her time at NINDS also served the Division of ... Translational Research in various capacities including holding a portfolio of small business awards in neurodegeneration and stroke. Prior to joining NINDS, she was a postdoctoral fellow at University of Maryland College Park and obtained her PhD in neuroscience from Johns Hopkins University, studying neural mechanisms of selective attention and experience dependent plasticity. She received her B.S. in Biological Sciences from Cornell University.

Hermon R. Gebrehiwet joined NINDS in December of 2021 as Scientific Program Manager in the Systems & Cognitive Neuroscience cluster. Hermon started her career with a bachelor's degree in Biochemistry and Physical Science. Then continued her education with a doctorate (DrPH) in ... Public Health with a concentration in epidemiology. Her work history includes Clinical Data Management (CDM) at the NIH/NCI Immunotherapy, Pediatric Oncology, and HIV and AIDS Malignancy Branch. Clinical trial management (CRA) and biostatistics work at Fast-Track Drugs and Biologics, as well as a research assistant at CDC/NCHS. She is also a veteran who served with the US Army National Guard in Washington DC for 8 years.